Diagnosis and prognosis of breast and ovarian cancer A population-based study of 234 women
暂无分享,去创建一个
[1] Zhao Rui,et al. Use of serological proteomic methods to find biomarkers associated with breast cancer , 2003, Proteomics.
[2] G Dhom,et al. Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study , 2002, British Journal of Cancer.
[3] B. Storer,et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. , 2002, Blood.
[4] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[5] J. Herod,et al. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit , 2002, BMJ : British Medical Journal.
[6] A. Ramirez,et al. A qualitative study of delay among women reporting symptoms of breast cancer. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.
[7] F. Frassoni,et al. Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study. , 2001, Blood.
[8] G. Hédelin,et al. Survival of women with breast cancer in France: variation with age, stage and treatment , 2001, Breast Cancer Research and Treatment.
[9] A. Håkansson,et al. Diagnostic Delay in Pediatric Malignancies - A Population-based Study , 2000, Acta oncologica.
[10] D. Parkin,et al. The performance of screening tests for ovarian cancer: results of a systematic review , 1999, British journal of obstetrics and gynaecology.
[11] F. Merlo,et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. , 1999, Blood.
[12] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.
[13] B. Haward,et al. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis , 1999, The Lancet.
[14] P. Littlejohns,et al. Influence of delay on survival in patients with breast cancer: a systematic review , 1999, The Lancet.
[15] P. Ljungman,et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. , 1999, Blood.
[16] E. Shaoul,et al. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.
[17] B. Weber,et al. BRCA1 and BRCA2: from molecular genetics to clinical medicine. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Ranstam,et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] P. DiSilvestro,et al. Prognostic value of clinical variables in ovarian cancer. , 1997, Journal of clinical epidemiology.
[20] J. Rodriguez-Sierra,et al. Younger women with breast carcinoma have a poorer prognosis than older women , 1996, Cancer.
[21] G. Hale,et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission , 1996, British journal of haematology.
[22] M. Labopin,et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia , 1996, British journal of haematology.
[23] T. Risberg,et al. Diagnostic delay causes more psychological distress in female than in male cancer patients. , 1996, Anticancer research.
[24] G. Dini,et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. , 1995, Blood.
[25] F. Pettersson,et al. Symptoms and diagnostic difficulties in ovarian epithelial cancer , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[26] F. Appelbaum. The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation. , 1993, Seminars in oncology.
[27] C. la Vecchia,et al. Descriptive epidemiology of ovarian cancer in Europe , 1993, Gynecologic oncology.
[28] J. Reiffers,et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO). , 1991, International journal of radiation oncology, biology, physics.
[29] S. Groshen,et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. , 1987, The New England journal of medicine.
[30] H. Deeg,et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. , 1986, Bone marrow transplantation.
[31] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[32] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.
[33] R. Hultborn,et al. The diagnosis of cancer in the "roar" of potential cancer symptoms of patients in primary health care. Research by means of the computerised journal. , 2001, Scandinavian journal of primary health care.
[34] J. Klein,et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] L. Skoog,et al. The general mammography screening program in Stockholm. Organisation and first-round results. , 1994, Acta oncologica.
[36] H. Sommer,et al. Patient's and doctor's delay in primary breast cancer. Prognostic implications. , 1994, Acta oncologica.
[37] J. Sanders. Endocrine problems in children after bone marrow tranplant for hematologic malignancies , 1991 .
[38] N. Einhorn†,et al. Symptomatology of ovarian cancer. , 1988, European journal of obstetrics, gynecology, and reproductive biology.
[39] T. Hakulinen,et al. A computer program package for relative survival analysis. , 1985, Computer programs in biomedicine.